These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 34542380)
1. Molecular modeling and dynamics studies of the synthetic small molecule agonists with GPR17 and P2Y1 receptor. Murugesan A; Nguyen P; Ramesh T; Yli-Harja O; Kandhavelu M; Saravanan KM J Biomol Struct Dyn; 2022; 40(23):12908-12916. PubMed ID: 34542380 [TBL] [Abstract][Full Text] [Related]
2. Identification of novel GPR17-agonists by structural bioinformatics and signaling activation. Saravanan KM; Palanivel S; Yli-Harja O; Kandhavelu M Int J Biol Macromol; 2018 Jan; 106():901-907. PubMed ID: 28827203 [TBL] [Abstract][Full Text] [Related]
3. Structural analysis of human G-protein-coupled receptor 17 ligand binding sites. Konda Mani S; Thiyagarajan R; Yli-Harja O; Kandhavelu M; Murugesan A J Cell Biochem; 2023 Apr; 124(4):533-544. PubMed ID: 36791278 [TBL] [Abstract][Full Text] [Related]
4. Agonist-induced desensitization/resensitization of human G protein-coupled receptor 17: a functional cross-talk between purinergic and cysteinyl-leukotriene ligands. Daniele S; Trincavelli ML; Gabelloni P; Lecca D; Rosa P; Abbracchio MP; Martini C J Pharmacol Exp Ther; 2011 Aug; 338(2):559-67. PubMed ID: 21531793 [TBL] [Abstract][Full Text] [Related]
5. GPR17: molecular modeling and dynamics studies of the 3-D structure and purinergic ligand binding features in comparison with P2Y receptors. Parravicini C; Ranghino G; Abbracchio MP; Fantucci P BMC Bioinformatics; 2008 Jun; 9():263. PubMed ID: 18533035 [TBL] [Abstract][Full Text] [Related]
6. The Orphan Receptor GPR17 Is Unresponsive to Uracil Nucleotides and Cysteinyl Leukotrienes. Simon K; Merten N; Schröder R; Hennen S; Preis P; Schmitt NK; Peters L; Schrage R; Vermeiren C; Gillard M; Mohr K; Gomeza J; Kostenis E Mol Pharmacol; 2017 May; 91(5):518-532. PubMed ID: 28254957 [TBL] [Abstract][Full Text] [Related]
7. The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor. Ciana P; Fumagalli M; Trincavelli ML; Verderio C; Rosa P; Lecca D; Ferrario S; Parravicini C; Capra V; Gelosa P; Guerrini U; Belcredito S; Cimino M; Sironi L; Tremoli E; Rovati GE; Martini C; Abbracchio MP EMBO J; 2006 Oct; 25(19):4615-27. PubMed ID: 16990797 [TBL] [Abstract][Full Text] [Related]
8. Is GPR17 a P2Y/leukotriene receptor? examination of uracil nucleotides, nucleotide sugars, and cysteinyl leukotrienes as agonists of GPR17. Qi AD; Harden TK; Nicholas RA J Pharmacol Exp Ther; 2013 Oct; 347(1):38-46. PubMed ID: 23908386 [TBL] [Abstract][Full Text] [Related]
9. Distinct expression and ligand-binding profiles of two constitutively active GPR17 splice variants. Benned-Jensen T; Rosenkilde MM Br J Pharmacol; 2010 Mar; 159(5):1092-105. PubMed ID: 20148890 [TBL] [Abstract][Full Text] [Related]
10. Functional characterization of two isoforms of the P2Y-like receptor GPR17: [35S]GTPgammaS binding and electrophysiological studies in 1321N1 cells. Pugliese AM; Trincavelli ML; Lecca D; Coppi E; Fumagalli M; Ferrario S; Failli P; Daniele S; Martini C; Pedata F; Abbracchio MP Am J Physiol Cell Physiol; 2009 Oct; 297(4):C1028-40. PubMed ID: 19625605 [TBL] [Abstract][Full Text] [Related]
11. Transcriptomic analysis of glioblastoma multiforme providing new insights into GPR17 signaling communication. Mutharasu G; Murugesan A; Konda Mani S; Yli-Harja O; Kandhavelu M J Biomol Struct Dyn; 2022 Apr; 40(6):2586-2599. PubMed ID: 33140689 [TBL] [Abstract][Full Text] [Related]
12. Forced unbinding of GPR17 ligands from wild type and R255I mutant receptor models through a computational approach. Parravicini C; Abbracchio MP; Fantucci P; Ranghino G BMC Struct Biol; 2010 Mar; 10():8. PubMed ID: 20233425 [TBL] [Abstract][Full Text] [Related]
13. Regulation of PC12 cell survival and differentiation by the new P2Y-like receptor GPR17. Daniele S; Lecca D; Trincavelli ML; Ciampi O; Abbracchio MP; Martini C Cell Signal; 2010 Apr; 22(4):697-706. PubMed ID: 20056144 [TBL] [Abstract][Full Text] [Related]
14. A promiscuous recognition mechanism between GPR17 and SDF-1: Molecular insights. Parravicini C; Daniele S; Palazzolo L; Trincavelli ML; Martini C; Zaratin P; Primi R; Coppolino G; Gianazza E; Abbracchio MP; Eberini I Cell Signal; 2016 Jun; 28(6):631-42. PubMed ID: 26971834 [TBL] [Abstract][Full Text] [Related]
15. In silico identification of new ligands for GPR17: a promising therapeutic target for neurodegenerative diseases. Eberini I; Daniele S; Parravicini C; Sensi C; Trincavelli ML; Martini C; Abbracchio MP J Comput Aided Mol Des; 2011 Aug; 25(8):743-52. PubMed ID: 21744154 [TBL] [Abstract][Full Text] [Related]
16. Frontal affinity chromatography-mass spectrometry useful for characterization of new ligands for GPR17 receptor. Calleri E; Ceruti S; Cristalli G; Martini C; Temporini C; Parravicini C; Volpini R; Daniele S; Caccialanza G; Lecca D; Lambertucci C; Trincavelli ML; Marucci G; Wainer IW; Ranghino G; Fantucci P; Abbracchio MP; Massolini G J Med Chem; 2010 May; 53(9):3489-501. PubMed ID: 20394377 [TBL] [Abstract][Full Text] [Related]